Franklin Resources Inc Gossamer Bio, Inc. Transaction History

Franklin Resources Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 13, 2021	SELL	$8.63 - $10.94 $6.65 Million - $8.43 Million	-770,365 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$8.3 - $13.59 $2.18 Million - $3.57 Million	-262,935 Reduced 25.45%	770,365 $7.45 Million
Q2 2020 Aug 13, 2020	BUY	$9.52 - $15.98 $5.24 Million - $8.79 Million	550,000 Added 113.8%	1,033,300 $14.7 Million
Q1 2020 May 13, 2020	SELL	$8.0 - $15.48 $923,200 - $1.79 Million	-115,400 Reduced 19.28%	483,300 $4.91 Million
Q4 2019 Feb 12, 2020	SELL	$14.82 - $26.79 $389,766 - $704,577	-26,300 Reduced 4.21%	598,700 $9.36 Million
Q1 2019 May 14, 2019	BUY	$17.58 - $23.97 $11 Million - $15 Million	625,000 New	625,000 $13.5 Million

116

168M

1.42M

92.6K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $117M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.